Thyroid

If you’ve been researching weight loss injections in India, you’ve probably come across two names everywhere: Mounjaro and Ozempic. Both belong to the GLP-1 class of medications, both require a weekly injection, and both can produce serious weight loss results. But they’re not the same drug, and picking the wrong one could mean slower progress or unnecessary side effects. Here’s what actually matters when comparing these two, based on clinical data and what we see in practice at Asian Diabetes Thyroid Hormone Super Specialty Center. KEY TAKEAWAYS Mounjaro (tirzepatide) targets two hormones (GIP + GLP-1), while Ozempic (semaglutide) targets only GLP-1. A JAMA Internal Medicine study found Mounjaro patients were 3x more likely to hit 15% weight loss than Ozempic patients. Mounjaro costs ₹14,000–₹17,500/month in India. Ozempic starts around ₹8,800/month. Side effects are similar for both, mainly nausea and stomach discomfort in the first few weeks. An endocrinologist should decide which one fits your medical profile. Self-prescribing either drug is risky. How Do They Actually Work? Both drugs mimic a gut hormone called GLP-1 that your body naturally releases after eating. This hormone tells your brain you’re full, slows down digestion, and helps regulate blood sugar. The difference? Mounjaro doesn’t stop at GLP-1. It also activates a second hormone receptor called GIP (glucose-dependent insulinotropic polypeptide). Think of Ozempic as working through one channel and Mounjaro working through two. That dual action is a big part of why Mounjaro tends to produce more weight loss in clinical settings. Ozempic (semaglutide) has been around longer and has stronger cardiovascular data behind it. If you have heart disease along with obesity or diabetes, that’s a factor your doctor will weigh carefully. Weight Loss Results: What the Studies Say Forget the marketing. Here’s what the research found. A real-world study published in JAMA Internal Medicine in 2024 analyzed health records of over 18,000 adults with overweight or obesity. The findings were clear: patients on tirzepatide (Mounjaro) were three times more likely to achieve 15% body weight loss compared to those on semaglutide (Ozempic). In clinical trials, the numbers break down roughly like this: Ozempic users lost an average of about 15% of their body weight over 68 weeks. Mounjaro users lost up to 21–22% of their body weight at the highest dose over 72 weeks. At the lowest dose (5 mg), average weight loss was around 15.4 kg. At the highest dose (15 mg), it was 21.8 kg. Those are averages. Individual results depend on your starting weight, diet, activity level, and whether you have conditions like insulin resistance, PCOS, or thyroid disorders that affect metabolism. Cost in India This is where things get practical. Both drugs are now available in India, and cost matters. Mounjaro launched in India in March 2025. It’s priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for a 5 mg vial. Monthly cost ranges from ₹14,000 to ₹17,500 depending on your prescribed dose. That’s roughly one-fifth of what it costs in the US. Ozempic became officially available in India in December 2025. Monthly cost starts at ₹8,800 for the 0.25 mg dose and goes up to ₹11,175 for the 1 mg dose. Neither drug is covered by most Indian health insurance plans unless your doctor justifies it for diabetes management specifically. Worth checking with your insurer before starting. Side Effects: What to Expect The side effect profile is similar for both medications. Most patients experience some combination of: Nausea (especially in the first 2–4 weeks) Stomach discomfort or bloating Diarrhea or constipation Reduced appetite (this is partly how the drugs work) These side effects usually settle down as your body adjusts. Starting at a low dose and increasing gradually makes a big difference, which is why proper medical supervision matters. Serious side effects are rare but possible. Pancreatitis, gallbladder issues, and thyroid-related concerns have been reported in clinical trials for both drugs. Neither should be used if you have a personal or family history of medullary thyroid cancer. Who Should Take What? There’s no universal answer. The right choice depends on your specific medical situation. Mounjaro might be a better fit if: Your primary goal is significant weight loss (BMI 30+) You have type 2 diabetes along with obesity You haven’t responded well to other weight loss approaches You have PCOS-related weight gain or insulin resistance Ozempic might be a better fit if: You have established cardiovascular disease (the SELECT trial showed 20% fewer heart attacks and strokes) You need a more affordable monthly option Your weight loss goal is moderate You’re already on a diabetes management plan and need blood sugar control In many cases, an endocrinologist will start you on one and adjust based on how your body responds over the first 8–12 weeks. Why Medical Supervision Matters This part gets buried under the social media hype: these are prescription medications, not lifestyle products. Taking GLP-1 injections without proper evaluation can mask underlying conditions, create nutritional deficiencies, or cause complications that wouldn’t happen with proper monitoring. At Asian Diabetes Thyroid Hormone Super Specialty Center, Dr. Shalini Patlolla evaluates every patient’s hormone profile, thyroid function, insulin resistance levels, and overall metabolic health before recommending either Mounjaro or Ozempic. The dosing gets adjusted based on your response, not based on a generic protocol. If you’re considering weight loss injections, the first step isn’t choosing between Mounjaro and Ozempic. It’s getting a proper endocrine evaluation so the choice is based on your actual health data. So Which One Should You Pick? Both drugs work. That’s not the debate anymore. Mounjaro tends to produce more weight loss, while Ozempic has better cardiovascular outcome data and costs less per month. But neither replaces the basics — dietary changes, physical activity, and consistent medical follow-up still do the heavy lifting. Don’t pick a weight loss injection based on what worked for someone on Instagram. Get evaluated by an endocrinologist who can look at your bloodwork, your metabolic profile, and your medical history before making a recommendation.